World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
50
Citations
15620
World Ranking
4188
National Ranking
1910

Markus Mohrs publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Markus Mohrs sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 77 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Markus Mohrs D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Markus Mohrs sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 50 D-Index — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Markus Mohrs is affiliated with the Trudeau Institute in the United States. Their research primarily spans the fields of Immunology and Microbiology, Medicine, and Biochemistry, Genetics and Molecular Biology. Within these broader areas, their work focuses notably on Immunology, Oncology, Surgery, Molecular Biology, and Cancer Research.

Their research topics encompass several specialized subjects, including:

  • IL-33, ST2, and ILC Pathways
  • Eosinophilic Esophagitis
  • CAR-T cell therapy research
  • Single-cell and spatial transcriptomics
  • Immune cells in cancer
  • Cancer Genomics and Diagnostics
  • Galectins and Cancer Biology

Markus Mohrs has contributed to multiple publications, with recent papers covering a range of immunological and oncological topics. These include:

  • "Heterogeneity and chimerism of endothelial cells revealed by single-cell transcriptome in orthotopic liver tumors," 2020, published in Angiogenesis
  • "Campylobacter infection promotes IFNγ-dependent intestinal pathology via ILC3 to ILC1 conversion," 2020, published in Mucosal Immunology
  • "Human CD4 cytotoxic T lymphocytes mediate potent tumor control in humanized immune system mice," 2023, published in Communications Biology
  • "Correction to: Campylobacter infection promotes IFNγ-dependent intestinal pathology via ILC3 to ILC1 conversion," 2021, published in Mucosal Immunology
  • "851 Voyager V1 (VV1) oncolytic virus combined with immune checkpoint therapy boosts CTL responses to multiple tumor antigens and correspondingly deepens tumor responses in murine models of melanoma, lung and colon cancer," 2022, published in Regular and Young Investigator Award Abstracts

Mohrs frequently collaborates with several researchers, including Gavin Thurston, Wayne T. Muraoka, Anna А. Korchagina, Qingqing Xia, and Sergey A. Shein. The majority of their joint work appears in journals such as Mucosal Immunology, Angiogenesis, Communications Biology, and abstract compilations like Regular and Young Investigator Award Abstracts.

Best Publications

  • Requirement for IL-13 independently of IL-4 in experimental asthma

    G. Grünig;M. Warnock;A. E. Wakil;R. Venkayya

  • Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology.

    De'Broski R Herbert;Christoph Hölscher;Markus Mohrs;Berenice Arendse

  • Constitutive Cytokine mRNAs Mark Natural Killer (NK) and NK T Cells Poised for Rapid Effector Function

    Daniel B. Stetson;Markus Mohrs;R. Lee Reinhardt;Jody L. Baron

  • Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter.

    Markus Mohrs;Kanade Shinkai;Katja Mohrs;Richard M Locksley

  • Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets.

    Jane L. Grogan;Markus Mohrs;Brian Harmon;Dee A. Lacy

  • Aluminium Hydroxide Adjuvant Initiates Strong Antigen-Specific Th2 Responses in the Absence of IL-4- or IL-13-Mediated Signaling

    James M. Brewer;Margaret Conacher;Christopher A. Hunter;Markus Mohrs

  • T follicular helper cells differentiate from Th2 cells in response to helminth antigens

    Arielle Glatman Zaretsky;Justin J. Taylor;Irah L. King;Fraser A. Marshall

  • IL-4 producing CD4+ T cells in reactive lymph nodes during helminth infection are T follicular helper cells

    Irah L. King;Markus Mohrs

  • Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses.

    Bart Everts;Georgia Perona-Wright;Hermelijn H. Smits;Cornelis H. Hokke

  • Mast Cells, Basophils, and Eosinophils Acquire Constitutive IL-4 and IL-13 Transcripts during Lineage Differentiation That Are Sufficient for Rapid Cytokine Production

    André Gessner;Katja Mohrs;Markus Mohrs

  • Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling.

    Markus Mohrs;Birgit Ledermann;Gabriele Köhler;Andreas Dorfmüller

  • Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils.

    Lauren Cohn;Robert J. Homer;Heather MacLeod;Markus Mohrs

  • Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection

    P'ng Loke;Iain Gallagher;Meera G Nair;Meera G Nair;Xingxing Zang

  • Nonredundant Roles for B Cell-Derived IL-10 in Immune Counter-Regulation

    Rajat Madan;Filiz Demircik;Sangeetha Surianarayanan;Jessica L. Allen

  • A Two-Step Process for Cytokine Production Revealed by IL-4 Dual-Reporter Mice

    Katja Mohrs;Adil E. Wakil;Nigel Killeen;Richard M. Locksley

  • Mouse Vα14i natural killer T cells are resistant to cytokine polarization in vivo

    Jennifer L. Matsuda;Laurent Gapin;Jody L. Baron;Stéphane Sidobre

  • Differences between IL-4Rα-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses

    Marijke Barner;Markus Mohrs;Frank Brombacher;Manfred Kopf

  • Schistosome-derived omega-1 drives Th2 polarization by suppressing protein synthesis following internalization by the mannose receptor

    Bart Everts;Leonie Hussaarts;Nicole N. Driessen;Moniek H.J. Meevissen

  • Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus

    Wojciech Wojciechowski;David P. Harris;Frank Sprague;Betty Mousseau

  • Helper T cells regulate type-2 innate immunity in vivo

    Kanade Shinkai;Markus Mohrs;Richard M. Locksley

  • Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology (vol 20, pg 623, 2004)

    D. R. Herbert;C. Holscher;M. Mohrs;B. Arendse

Frequent Co-Authors

Frank Brombacher
Frank Brombacher University of Cape Town
Richard M. Locksley
Richard M. Locksley University of California, San Francisco
Edward J. Pearce
Edward J. Pearce Johns Hopkins University
David L. Woodland
David L. Woodland Trudeau Institute
David Artis
David Artis Cornell University
Frances E. Lund
Frances E. Lund University of Alabama at Birmingham
Walter Sebald
Walter Sebald University of Würzburg
Albert Duschl
Albert Duschl University of Salzburg
Helmut L. Haas
Helmut L. Haas Heinrich Heine University Düsseldorf
Gurdyal S. Besra
Gurdyal S. Besra University of Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students pursuing Immunology in the USA, exploring related healthcare fields online can broaden career opportunities. Many professionals consider advancing their careers with an accelerated nurse practitioner program, which offers a faster track to becoming a Nurse Practitioner (NP). These programs are designed for those seeking a quick and comprehensive route to clinical practice.

Nurses transitioning to specialized roles often aim for acute care NP certification. This credential is key for those wanting to work with critically ill patients in hospital settings. It signals expertise beyond general practice and is often a stepping stone to more advanced clinical roles.

Understanding salary prospects is also crucial. Interested individuals can review the dnp salary by state to better gauge regional earning potential and make informed decisions about where to study or work.

For those coming from non-nursing backgrounds, there are excellent online nursing programs for non nurses that provide foundational and advanced knowledge needed to enter the healthcare profession smoothly. These programs help diversify the pipeline of healthcare professionals with varied expertise, including those focusing on immunological research and patient care.

Best Scientists Citing Markus Mohrs

Trending Scientists

Recently Published Articles